Cornerstone Planning Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.2K Sell
219
-2
-0.9% -$685 0.01% 290
2026
Q1
$72.6K Buy
221
+46
+26% +$16.4K 0.01% 311
2025
Q4
$59.9K Sell
175
-9
-5% -$2.85K 0.01% 304
2025
Q3
$53.7K Buy
184
+82
+80% +$23.8K 0.01% 327
2025
Q2
$30.5K Buy
102
+2
+2% +$567 0.01% 327
2025
Q1
$27.9K Buy
100
+29
+41% +$8.56K 0.01% 340
2024
Q4
$20.1K Buy
71
+1
+1% +$297 ﹤0.01% 309
2024
Q3
$22.1K Buy
70
+4
+6% +$1.31K 0.01% 288
2024
Q2
$21.4K Buy
66
+31
+89% +$9.11K 0.01% 306
2024
Q1
$10.7K Buy
35
+10
+40% +$2.93K ﹤0.01% 392
2023
Q4
$7.31K Sell
25
-4
-14% -$1.09K ﹤0.01% 479
2023
Q3
$7.87K Buy
29
+5
+21% +$1.25K ﹤0.01% 468
2023
Q2
$5.39K Buy
+24
New +$5.57K ﹤0.01% 870
2022
Q4
$11.8K Buy
+44
New +$11.8K ﹤0.01% 582

Other funds holding AMGN

Cornerstone Planning Group's AMGN Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Amgen (AMGN) stake by 0.9% in Q2 2026, selling an estimated $685 and leaving 219 shares worth $80.2K. The position accounts for 0.01% of the portfolio, ranked #290.

Cornerstone Planning Group first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cornerstone Planning Group held 219 shares of Amgen worth $80.2K as of Q2 2026.
  • Cornerstone Planning Group sold 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #290 holding.
  • Cornerstone Planning Group first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.